AN2 Therapeutics Cash from Financing (TTM) Trends

AN2 Therapeutics Inc (ANTX)

2.48 +0.09 (+3.77%) USD | NASDAQ | May 02, 10:58

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	84.99M
September 30, 2023	85.32M
June 30, 2023	19.24M
March 31, 2023	7.367M
December 31, 2022	70.36M

Date	Value
September 30, 2022	69.39M
June 30, 2022	69.16M
March 31, 2022	61.98M
December 31, 2021	78.54M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

7.367M

Minimum

Mar 2023

85.32M

Maximum

Sep 2023

60.70M

Average

69.39M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks